GMI

Resveratrol adds to the growth inhibitory/anticancer activity of cisplatin and doxorubicin in vitro and protects against doxorubicin-induced cardiac toxicity both in vitro and in mice.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *